The intermediate filament peripherin is expressed in cutaneous melanocytic lesions

Journal of Cutaneous Pathology

Volumn 24, Issue 3, 1997, Pages 145-150

  Prieto, Victor G ^a,c   McNutt, N Scott ^a   Lugo, Jorge ^a,b   Reed, Jon A ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b IMPATH Inc   (United States)

^c Division of Dermatopathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; MELANIN; PERIPHERIN;

ARTICLE; BLUE NEVUS; CELLULAR DISTRIBUTION; DENDRITIC CELL; DERMIS; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; JUVENILE MELANOMA; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; NERVE CELL DIFFERENTIATION; NEVUS; NEVUS CELL; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; TUMOR CELL;

ADULT; DENDRITIC CELLS; EYE PROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; INTERMEDIATE FILAMENTS; MELANOCYTES; MELANOMA; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; NEVUS; SKIN NEOPLASMS;

EID: 0030972329     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb01568.x     Document Type: Article

References (37)

1. Portier MM, Croizat B, Gros F. A sequence of changes in cytoskeletal components during neuroblastoma differentiation. FEBS Lett 1982: 146: 283.
2. Portier MM, de Nechaud B, Gros F. Peripherin a new member of the intermediate filament protein family. Dev Neurosci 1983/1984: 6: 335.
3. Moncla A, Landon F, Mattei MG, Portier MM. Chromosomal localisation of the mouse and human peripherin genes. Genet Res 1992: 59: 125.
4. Blumenfeld A, Lucente DE, Trofatter JA, et al. Peripherin gene is linked to keratin 18 gene on human chromosome 12. Somat Cell Mol Genet 1995: 21: 83.
5. Farrar GJ, Kenna P, Jordan SA, et al. A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa. Nature 1991: 354: 478.
6. Thompson MA, Ziff EB. Structure of the gene encoding peripherin, an NGF-regulated neuronal-specific type III intermediate filament protein. Neuron 1989: 2: 1043.
7. Escurat M, Djabali K, Hue C, et al. Origin of the b cells of the islets of Langerhans cells is further questioned by the expression of neuronal intermediate filament proteins, peripherin NF-1, in the rat insulinoma RIN5F cell line. Dev Neurosci 1991: 13: 424.
8. Pedersen WA, Becker LE, Yeger H. Expression and distribution of peripherin protein in human neuroblastoma cell lines. Int J Cancer 1993: 53: 463.
9. Baudoin C, Meneguzzi G, Portier MM, et al. Peripherin, a neuronal intermediate protein, is stably expressed by neuroendocrine carcinomas of the skin, their xenograft on nude mice, and the corresponding primary cultures. Cancer Res 1993: 53: 1175.
10. Moll I, Kuhn C, Moll R. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. Lab Invest 1995: 104: 910.
11. Escurat M, Gumpel M, Lachapelle F, Gros F, Portier MM. Expression comparée de deux proteins de filaments intermediaires, la peripherin et la proteine de neurofilament 68 Kda, au cours du developpement embryonnaire du rat. Comptes Rendus Acad Sci Paris 1988: 306: 447.
12. Wong J, Oblinger MM. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons. J Neurosci Res 1990: 27: 332.
13. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 1993: 11: 595.
14. Lam BL, Vandenburgh K, Sheffield VC, Stone EM. Retinitis pigmentosa associated with a dominant mutation in codon 46 of the peripherin/RDS gene (arginine-46-stop). Am J Ophthalmol 1995: 119: 65.
15. Johnson FB. Pigments and minerals. In: Prophet EB, Mills B, Arrington JB, Sobin LH, eds. Laboratory methods in histotechnology. Washington DC: American Registry of Pathology, 1992: 186.
16. Reed JA, Manahan LJ, Park CS, Brigatti DJ. Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992: 13: 434.
17. Du Shane GP. The origin of pigment cells in Amphibia. Science 1934: 89: 620.
18. LeDuorain N. The neural crest. In: Bailow PW, Green FB Wylie CC, eds. Developmental and cell biology series. New York: Cambridge University Press, 1982: 111.
19. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Ishihara K. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus. and its diagnostic application. Cancer 1982: 50: 912.
20. Aso M, Hashimoto K, Eto H, et al. Expression of Schwann cell characteristics in pigmented nevus. Immunohistochemical study using monoclonal antibody 10 Schwann cell associated antigen. Cancer 1988: 62: 938.
21. Orchard G, Wilson Jones E. Immunocytochemistry in the diagnosis of malignant melanoma. Br J Biomed Sci 1994: 51: 44.
22. Miettinen M, Foidart JM, Ekblom P. Immunohistochemical demonstration of laminin, the major glycoprotein of basement membranes, as an aid in the diagnosis of soft tissue tumors. Am J Clin Pathol 1983: 79: 306.
23. Gay RE, Gay S, Jones RE. Histological and immunohistological identification of collagens in basement membranes of Schwann cells of neurofibromas. Am J Dermatopathol 1983: 5: 317.
24. Stenbäck F, Wasenius V-M. Occurrence of basement membranes in pigment cell tumors of the skin, relation to cell type and clinical behavior. J Cutan Pathol 1986: 13: 175.
25. Mishima Y. Macromolecular changes in pigmentary disorders. Arch Dermatol 1965: 91: 519.
26. Penneys NS, Mogollon R, Kowalczyk A, Nadji M, Adachi K. A survey of cutaneous neural lesions for the presence of myelin basic protein: An immunohistochemical study. Arch Dermatol 1984: 120: 210.
27. Lever WF, Schaumburg-Lever G. Histopathology of the skin, 7th ed. Philadelphia: JB Lippincott Company, 1990: 757.
28. Paul E, Wen DR, Cochran AJ. Variations in S-100 protein expression in naevocellular nevi may be related to metabolic activity. Br J Dermatol 1987: 116: 371.
29. Thorne EG, Mottaz JH, Zelickson AS. Tyrosinase activity in dermal nevus cells. Arch Dermatol 1971: 104: 619.
30. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1986: 123: 195.
31. Colombari R, Bonetti Zamboni G, Scarpa A, et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections. Virchows Arch Anat Pathol 1988: 413: 17.
32. Wick MR, Swanson PE, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988: 15: 201.
33. Palazzo JO, Duray PH. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study. Human Pathol 1989: 20: 341.
34. Skelton HG, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol 1991: 13: 543.
35. McNutt NS, Urmacher C, Hakimian J, Moss DM, Lugo J. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol 1995: 22: 502.
36. Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 1995: 17: 542.
37. Schaumberg-Lever G, Metzler G, Kuiserling E. Ultrastructural localization of HMB45 binding sites. J Cutan Pathol 1991: 18: 432.